Literature DB >> 3006423

Best's vitelliform macular dystrophy.

V Godel, G Chaine, L Regenbogen, G Coscas.   

Abstract

We examined and evaluated the ophthalmological findings of 47 patients with Best's Vitelliform Macular Dystrophy (BVMD) and 5 cases suffering from related conditions to this macular disorder. Our sample re-confirm that BVMD is a progressive disease which may have several appearances in the course of its evolution. The heredity of this disorder is autosomal dominant with reduced penetrance and variable expressivity. Some contradictions exist regarding the nature of the primary defect in this entity. Electrooculographic and angiographic investigations lend support to the belief that the basic pathological changes are located in the retinal pigment epithelium. However, recent histopathological findings and flicker electroretinographic results indicate the possibility that the photoreceptor cells are equally involved, even before the pigment epithelium. In view of the existing disagreements about the pathogenesis of this disorder, certain considerations were advanced which suggest that the basic pathologic process in this entity produces a disorganisation in the structural and functional interdependance of both the photoreceptor cells and pigment epithelium.

Entities:  

Mesh:

Year:  1986        PMID: 3006423

Source DB:  PubMed          Journal:  Acta Ophthalmol Suppl


  13 in total

1.  Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium.

Authors:  A D Marmorstein; L Y Marmorstein; M Rayborn; X Wang; J G Hollyfield; K Petrukhin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Best's multiple vitelliform degeneration.

Authors:  A Pece; G Gaspari; P Avanza; R Magni; R Brancato
Journal:  Int Ophthalmol       Date:  1992-11       Impact factor: 2.031

Review 3.  [Morbus Best].

Authors:  O Strauss
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

4.  Behavioural disturbance as a manifestation of ocular disease in children.

Authors:  L M Yeo; S T Ruben; H E Willshaw
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

5.  Hydrodynamic properties of porcine bestrophin-1 in Triton X-100.

Authors:  J Brett Stanton; Andrew F X Goldberg; George Hoppe; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Biochim Biophys Acta       Date:  2006-03-06

6.  Best's macular dystrophy in Australia: phenotypic profile and identification of novel BEST1 mutations.

Authors:  A C Cohn; C Turnbull; J B Ruddle; R H Guymer; L S Kearns; S Staffieri; H T Daggett; A W Hewitt; D A Mackey
Journal:  Eye (Lond)       Date:  2010-11-26       Impact factor: 3.775

7.  New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy.

Authors:  D Marchant; K Yu; K Bigot; O Roche; A Germain; D Bonneau; V Drouin-Garraud; D F Schorderet; F Munier; D Schmidt; P Le Neindre; C Marsac; M Menasche; J L Dufier; R Fischmeister; C Hartzell; M Abitbol
Journal:  J Med Genet       Date:  2007-02-07       Impact factor: 6.318

8.  A model of best vitelliform macular dystrophy in rats.

Authors:  Alan D Marmorstein; J Brett Stanton; John Yocom; Benjamin Bakall; Marc T Schiavone; Claes Wadelius; Lihua Y Marmorstein; Neal S Peachey
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-10       Impact factor: 4.799

9.  Pattern dystrophy of the retinal pigment epithelium.

Authors:  K U Duinkerke-Eerola; A Pinckers; J R Cruysberg
Journal:  Int Ophthalmol       Date:  1987-12       Impact factor: 2.031

10.  Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene.

Authors:  Giuseppe Querques; Jennyfer Zerbib; Rossana Santacroce; Maurizio Margaglione; Nathalie Delphin; Jean-Michel Rozet; Josseline Kaplan; Domenico Martinelli; Nicola Delle Noci; Gisèle Soubrane; Eric H Souied
Journal:  Mol Vis       Date:  2009-12-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.